GlaxoSmithKline PLC (NYSE:GSK)

46.46
BATS BZX Real-Time Price
As of 12:48pm ET
 +0.99 / +2.18%
Today’s Change
33.53
Today|||52-Week Range
46.84
+5.35%
Year-to-Date
Catalyst Pharmaceuticals: A Biotech Stock Worth Owning
6:53am / StockNews.com - Paid Partner Content
Glaxo (GSK) Rejects Unilever's $68B Bid for Consumer Business
Jan 17 / Zacks.com - Paid Partner Content
BlackRock cares about money, not 'woke' politics
3:03am / CNN.com
2 Best COVID-19 Growth Stocks to Own in 2022
Jan 17 / MotleyFool.com - Paid Partner Content
Dodge & Cox Global Stock Fund's 4th-Quarter Commentary
Jan 17 / GuruFocus News - Paid Partner Content
GlaxoSmithKline - Catalysts Ahead
Jan 17 / GuruFocus News - Paid Partner Content
Dodge & Cox Stock Fund's 4th-Quarter Commentary
Jan 17 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Pfizer (PFE), Beam Therapeutics, AbbVie, Merck and Glaxo
Jan 17 / Zacks.com - Paid Partner Content
GlaxoSmithKline Says 'No' 3 Times
Jan 17 / GuruFocus News - Paid Partner Content
The owner of Ben & Jerry's wants to buy Aquafresh and Advil
Jan 17 / CNN.com

Today’s Trading

Previous close45.47
Today’s open46.37
Day’s range46.31 - 46.84
Volume5,250,339
Average volume (3 months)4,050,549
Market cap$114.4B
Data as of 12:48pm ET, 01/18/2022

Growth & Valuation

Earnings growth (last year)+23.68%
Earnings growth (this year)-63.61%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+1.55%
P/E ratio20.1
Price/Sales2.12
Price/Book5.68

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.04-0.08%
ZTSZoetis Inc-2.97-1.44%
BMYBristol-Myers Squibb-0.26-0.40%
----
Data as of 12:48pm ET, 01/18/2022

Financials

Next reporting dateApril 27, 2022
EPS forecast (this quarter)$0.64
Annual revenue (last year)$43.7B
Annual profit (last year)$7.4B
Net profit margin16.86%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Middlesex, Greater London

Forecasts